Artículos de revistas sobre el tema "Pathological hypertrophy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Pathological hypertrophy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Li, Wei-ming, Yi-fan Zhao, Guo-fu Zhu, Wen-hui Peng, Meng-yun Zhu, Xue-jing Yu, Wei Chen, Da-chun Xu y Ya-wei Xu. "Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload". Clinical Science 131, n.º 2 (23 de diciembre de 2016): 141–54. http://dx.doi.org/10.1042/cs20160664.
Texto completoYu, Qing, Wenxin Kou, Xu Xu, Shunping Zhou, Peipei Luan, Xiaopeng Xu, Hailing Li et al. "FNDC5/Irisin inhibits pathological cardiac hypertrophy". Clinical Science 133, n.º 5 (1 de marzo de 2019): 611–27. http://dx.doi.org/10.1042/cs20190016.
Texto completoKang, Peter M., Patrick Yue, Zhilin Liu, Oleg Tarnavski, Natalya Bodyak y Seigo Izumo. "Alterations in apoptosis regulatory factors during hypertrophy and heart failure". American Journal of Physiology-Heart and Circulatory Physiology 287, n.º 1 (julio de 2004): H72—H80. http://dx.doi.org/10.1152/ajpheart.00556.2003.
Texto completoLi, Peng-Long, Hui Liu, Guo-Peng Chen, Ling Li, Hong-Jie Shi, Hong-Yu Nie, Zhen Liu et al. "STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy". Hypertension 76, n.º 4 (octubre de 2020): 1219–30. http://dx.doi.org/10.1161/hypertensionaha.120.14752.
Texto completoJACOB, R., M. VOGT y H. RUPP. "Physiological and pathological hypertrophy*". Journal of Molecular and Cellular Cardiology 18 (1986): 35. http://dx.doi.org/10.1016/s0022-2828(86)80135-3.
Texto completoTanaka, M., H. Fujiwara y C. Kawai. "Pathological features of hypertrophic cardiomyopathy without asymmetrical septal hypertrophy." Heart 56, n.º 3 (1 de septiembre de 1986): 294–97. http://dx.doi.org/10.1136/hrt.56.3.294.
Texto completoHu, Chengyun, Feibiao Dai, Jiawu Wang, Lai Jiang, Di Wang, Jie Gao, Jun Huang et al. "Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice". Oxidative Medicine and Cellular Longevity 2022 (29 de enero de 2022): 1–12. http://dx.doi.org/10.1155/2022/5067544.
Texto completoLu, Dan, Jizheng Wang, Jing Li, Feifei Guan, Xu Zhang, Wei Dong, Ning Liu, Shan Gao y Lianfeng Zhang. "Meox1 accelerates myocardial hypertrophic decompensation through Gata4". Cardiovascular Research 114, n.º 2 (16 de noviembre de 2017): 300–311. http://dx.doi.org/10.1093/cvr/cvx222.
Texto completoGao, Si, Xue-ping Liu, Li-hua Wei, Jing Lu y Peiqing Liu. "Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy". Canadian Journal of Physiology and Pharmacology 96, n.º 4 (abril de 2018): 352–58. http://dx.doi.org/10.1139/cjpp-2017-0282.
Texto completoLuckey, Stephen W., Chris D. Haines, John P. Konhilas, Elizabeth D. Luczak, Antke Messmer-Kratzsch y Leslie A. Leinwand. "Cyclin D2 is a critical mediator of exercise-induced cardiac hypertrophy". Experimental Biology and Medicine 242, n.º 18 (13 de septiembre de 2017): 1820–30. http://dx.doi.org/10.1177/1535370217731503.
Texto completoZeitz, Michael J. y James W. Smyth. "Translating Translation to Mechanisms of Cardiac Hypertrophy". Journal of Cardiovascular Development and Disease 7, n.º 1 (10 de marzo de 2020): 9. http://dx.doi.org/10.3390/jcdd7010009.
Texto completoYuan, Yonggang, Wanzhong Peng, Yongxing Liu y Zesheng Xu. "Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats". International Journal of Immunopathology and Pharmacology 30, n.º 4 (22 de noviembre de 2017): 406–12. http://dx.doi.org/10.1177/0394632017742225.
Texto completoJoseph, Jacob, Lija Joseph, Nawal S. Shekhawat, Sulochana Devi, Junru Wang, Russell B. Melchert, Martin Hauer-Jensen y Richard H. Kennedy. "Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats". American Journal of Physiology-Heart and Circulatory Physiology 285, n.º 2 (agosto de 2003): H679—H686. http://dx.doi.org/10.1152/ajpheart.00145.2003.
Texto completoZhou, Ning, Shaunrick Stoll y Hongyu Qiu. "VCP represses pathological cardiac hypertrophy". Aging 9, n.º 12 (26 de diciembre de 2017): 2469–70. http://dx.doi.org/10.18632/aging.101357.
Texto completoShimizu, Ippei y Tohru Minamino. "Physiological and pathological cardiac hypertrophy". Journal of Molecular and Cellular Cardiology 97 (agosto de 2016): 245–62. http://dx.doi.org/10.1016/j.yjmcc.2016.06.001.
Texto completoKavazis, Andreas N. "Pathological vs. physiological cardiac hypertrophy". Journal of Physiology 593, n.º 17 (1 de septiembre de 2015): 3767. http://dx.doi.org/10.1113/jp271161.
Texto completoHarrison, Brooke C., Charles R. Roberts, David B. Hood, Meghan Sweeney, Jody M. Gould, Erik W. Bush y Timothy A. McKinsey. "The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression". Molecular and Cellular Biology 24, n.º 24 (15 de diciembre de 2004): 10636–49. http://dx.doi.org/10.1128/mcb.24.24.10636-10649.2004.
Texto completoLiao, Hai-han, Nan Zhang, Yan-yan Meng, Hong Feng, Jing-jing Yang, Wen-jin Li, Si Chen, Hai-ming Wu, Wei Deng y Qi-zhu Tang. "Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway". Oxidative Medicine and Cellular Longevity 2019 (6 de diciembre de 2019): 1–14. http://dx.doi.org/10.1155/2019/6304058.
Texto completoYang, Jin, Xuhui Feng, Qiong Zhou, Wei Cheng, Ching Shang, Pei Han, Chiou-Hong Lin, Huei-Sheng Vincent Chen, Thomas Quertermous y Ching-Pin Chang. "Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1–FoxM1 complex". Proceedings of the National Academy of Sciences 113, n.º 38 (6 de septiembre de 2016): E5628—E5635. http://dx.doi.org/10.1073/pnas.1525078113.
Texto completoBrown, R. Dale, S. Kelly Ambler, Min Li, Timothy M. Sullivan, Lauren N. Henry, Joseph T. Crossno, Carlin S. Long, Timothy P. Garrington y Kurt R. Stenmark. "MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension". American Journal of Physiology-Heart and Circulatory Physiology 304, n.º 2 (15 de enero de 2013): H269—H281. http://dx.doi.org/10.1152/ajpheart.00158.2012.
Texto completoBuss, Sebastian J., Johannes H. Riffel, Pratima Malekar, Marco Hagenmueller, Christina Asel, Min Zhang, Celine Weiss, Hugo A. Katus y Stefan E. Hardt. "Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy". American Journal of Physiology-Heart and Circulatory Physiology 302, n.º 2 (enero de 2012): H420—H430. http://dx.doi.org/10.1152/ajpheart.00211.2011.
Texto completoDeng, Yawen, Zhitong Li, Xiangbo An, Rui Fan, Yao Wang, Jiatian Li, Xiaolei Yang, Jiawei Liao y Yunlong Xia. "Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension". Oxidative Medicine and Cellular Longevity 2022 (22 de agosto de 2022): 1–16. http://dx.doi.org/10.1155/2022/1486157.
Texto completoKong, Sek Won, Natalya Bodyak, Patrick Yue, Zhilin Liu, Jeffrey Brown, Seigo Izumo y Peter M. Kang. "Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats". Physiological Genomics 21, n.º 1 (21 de marzo de 2005): 34–42. http://dx.doi.org/10.1152/physiolgenomics.00226.2004.
Texto completoAgo, Tetsuro y Junichi Sadoshima. "From Contractile Enhancement to Pathological Hypertrophy". Journal of the American College of Cardiology 66, n.º 3 (julio de 2015): 273–77. http://dx.doi.org/10.1016/j.jacc.2015.05.058.
Texto completoWehbe, Nadine, Suzanne Nasser, Gianfranco Pintus, Adnan Badran, Ali Eid y Elias Baydoun. "MicroRNAs in Cardiac Hypertrophy". International Journal of Molecular Sciences 20, n.º 19 (23 de septiembre de 2019): 4714. http://dx.doi.org/10.3390/ijms20194714.
Texto completoXie, Xin, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang y Hui-Hua Li. "The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation". Science Advances 5, n.º 5 (mayo de 2019): eaau0495. http://dx.doi.org/10.1126/sciadv.aau0495.
Texto completoWatson, Peter A., Jane E. B. Reusch, Sylvia A. McCune, Leslie A. Leinwand, Stephen W. Luckey, John P. Konhilas, David A. Brown et al. "Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise". American Journal of Physiology-Heart and Circulatory Physiology 293, n.º 1 (julio de 2007): H246—H259. http://dx.doi.org/10.1152/ajpheart.00734.2006.
Texto completoOldfield, Christopher J., Todd A. Duhamel y Naranjan S. Dhalla. "Mechanisms for the transition from physiological to pathological cardiac hypertrophy". Canadian Journal of Physiology and Pharmacology 98, n.º 2 (febrero de 2020): 74–84. http://dx.doi.org/10.1139/cjpp-2019-0566.
Texto completoŢarcă, Elena, Elena Cojocaru, Alina Costina Luca, Laura Mihaela Trandafir, Solange Tamara Roşu, Valentin Munteanu, Viorel Țarcă, Cristian Constantin Budacu y Claudia Florida Costea. "Unusual Case of Masseter Muscle Hypertrophy in Adolescence—Case Report and Literature Overview". Diagnostics 12, n.º 2 (16 de febrero de 2022): 505. http://dx.doi.org/10.3390/diagnostics12020505.
Texto completoHaines, Christopher D., Pamela A. Harvey y Leslie A. Leinwand. "Estrogens Mediate Cardiac Hypertrophy in a Stimulus-Dependent Manner". Endocrinology 153, n.º 9 (1 de septiembre de 2012): 4480–90. http://dx.doi.org/10.1210/en.2012-1353.
Texto completoQian, Yanxia, Mingming Zhang, Ningtian Zhou, Xiaohan Xu, Jiahui Zhang, Qiang Ding y Junhong Wang. "A long noncoding RNA CHAIR protects the heart from pathological stress". Clinical Science 134, n.º 13 (julio de 2020): 1843–57. http://dx.doi.org/10.1042/cs20200149.
Texto completoChen, Lijuan, Jia Huang, Yanxiao Ji, Xiaojing Zhang, Pixiao Wang, Keqiong Deng, Xi Jiang, Genshan Ma y Hongliang Li. "Tripartite motif 32 prevents pathological cardiac hypertrophy". Clinical Science 130, n.º 10 (1 de abril de 2016): 813–28. http://dx.doi.org/10.1042/cs20150619.
Texto completoAbibillaev, Damirbek y Fuat Kocyigit. "Athletic heart adaptation, pathological hypertrophy and sudden cardiac death". Heart, Vessels and Transplantation 4, Issue 2 (27 de mayo de 2020): 55. http://dx.doi.org/10.24969/hvt.2020.199.
Texto completoGrund, Andrea, Malgorzata Szaroszyk, Janina K. Döppner, Mona Malek Mohammadi, Badder Kattih, Mortimer Korf-Klingebiel, Anna Gigina et al. "A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload". Cardiovascular Research 115, n.º 1 (20 de junio de 2018): 71–82. http://dx.doi.org/10.1093/cvr/cvy154.
Texto completoSu, Dongmei, Sun Jing, Lina Guan, Qian Li, Huiling Zhang, Xiaobo Gao y Xu Ma. "Role of Nodal–PITX2C signaling pathway in glucose-induced cardiomyocyte hypertrophy". Biochemistry and Cell Biology 92, n.º 3 (junio de 2014): 183–90. http://dx.doi.org/10.1139/bcb-2013-0124.
Texto completoBi, Hai-Lian, Xiao-Li Zhang, Yun-Long Zhang, Xin Xie, Yun-Long Xia, Jie Du y Hui-Hua Li. "The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor". Science Advances 6, n.º 16 (abril de 2020): eaax4826. http://dx.doi.org/10.1126/sciadv.aax4826.
Texto completoIemitsu, Motoyuki, Takashi Miyauchi, Seiji Maeda, Satoshi Sakai, Tsutomu Kobayashi, Nobuharu Fujii, Hitoshi Miyazaki, Mitsuo Matsuda y Iwao Yamaguchi. "Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 281, n.º 6 (1 de diciembre de 2001): R2029—R2036. http://dx.doi.org/10.1152/ajpregu.2001.281.6.r2029.
Texto completoGrieco, Teresa, Vito Gomes, Alfredo Rossi, Carmen Cantisani, Maria Elisabetta Greco, Giovanni Rossi, Alvise Sernicola y Giovanni Pellacani. "The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series". Journal of Clinical Medicine 11, n.º 15 (31 de julio de 2022): 4474. http://dx.doi.org/10.3390/jcm11154474.
Texto completoNosenko, N. M., D. V. Shchehlov, M. Yu Mamonova y Ya E. Kudelskyi. "Left ventricular hypertrophy: differential diagnosis". Endovascular Neuroradiology 30, n.º 4 (11 de marzo de 2020): 49–58. http://dx.doi.org/10.26683/2304-9359-2019-4(30)-49-58.
Texto completoYalçin, Fatih, Nagehan Kucukler, Oscar Cingolani, Blaid Mbiyangandu, Lars Sorensen, Aurelio Pinherio, M. Roselle Abraham y Theodore P. Abraham. "Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy". Journal of Applied Physiology 126, n.º 2 (1 de febrero de 2019): 354–62. http://dx.doi.org/10.1152/japplphysiol.00199.2016.
Texto completoGesmundo, Iacopo, Michele Miragoli, Pierluigi Carullo, Letizia Trovato, Veronica Larcher, Elisa Di Pasquale, Mara Brancaccio et al. "Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure". Proceedings of the National Academy of Sciences 114, n.º 45 (25 de octubre de 2017): 12033–38. http://dx.doi.org/10.1073/pnas.1712612114.
Texto completoPeng, Shi, Xiao-feng Lu, Yi-ding Qi, Jing Li, Juan Xu, Tian-you Yuan, Xiao-yu Wu et al. "LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway". Oxidative Medicine and Cellular Longevity 2020 (18 de septiembre de 2020): 1–15. http://dx.doi.org/10.1155/2020/9815039.
Texto completoGallo, Simona, Annapia Vitacolonna, Alessandro Bonzano, Paolo Comoglio y Tiziana Crepaldi. "ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy". International Journal of Molecular Sciences 20, n.º 9 (1 de mayo de 2019): 2164. http://dx.doi.org/10.3390/ijms20092164.
Texto completoDobrzyn, Pawel, Aleksandra Pyrkowska, Monika K. Duda, Tomasz Bednarski, Michal Maczewski, Jozef Langfort y Agnieszka Dobrzyn. "Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy". American Journal of Physiology-Endocrinology and Metabolism 304, n.º 12 (15 de junio de 2013): E1348—E1358. http://dx.doi.org/10.1152/ajpendo.00603.2012.
Texto completoLi, Haobo, Lena E. Trager, Xiaojun Liu, Margaret H. Hastings, Chunyang Xiao, Justin Guerra, Samantha To et al. "lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth". Circulation 145, n.º 16 (19 de abril de 2022): 1218–33. http://dx.doi.org/10.1161/circulationaha.121.056850.
Texto completoPiven, O. O. "Signalling function of β-catenin is important at early stages of adult heart pathological hypertrophy". Visnik ukrains'kogo tovaristva genetikiv i selekcioneriv 14, n.º 1 (20 de junio de 2016): 44–51. http://dx.doi.org/10.7124/visnyk.utgis.14.1.543.
Texto completoRen, Zongna, Peng Yu, Dandan Li, Zheng Li, Yingnan Liao, Yin Wang, Bingying Zhou y Li Wang. "Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy". Circulation 141, n.º 21 (26 de mayo de 2020): 1704–19. http://dx.doi.org/10.1161/circulationaha.119.043053.
Texto completoLiu, Yaoqiu, Yahui Shen, Jingai Zhu, Ming Liu, Xing Li, Yumei Chen, Xiangqing Kong, Guixian Song y Lingmei Qian. "Cardiac-Specific PID1 Overexpression Enhances Pressure Overload-Induced Cardiac Hypertrophy in Mice". Cellular Physiology and Biochemistry 35, n.º 5 (2015): 1975–85. http://dx.doi.org/10.1159/000374005.
Texto completoLi, Jin, Zhao Sha, Xiaolan Zhu, Wanru Xu, Weilin Yuan, Tingting Yang, Bing Jin et al. "Targeting miR-30d reverses pathological cardiac hypertrophy". eBioMedicine 81 (julio de 2022): 104108. http://dx.doi.org/10.1016/j.ebiom.2022.104108.
Texto completoLi, Zhenhua, Jian Wang y Xiao Yang. "Functions of Autophagy in Pathological Cardiac Hypertrophy". International Journal of Biological Sciences 11, n.º 6 (2015): 672–78. http://dx.doi.org/10.7150/ijbs.11883.
Texto completo